Complex concepts made visual. Explore the future of medicine through animated, interactive diagrams.
How organoids, organ-on-chip, digital twins, and AI work together to replace animal testing - an interactive map of the entire ecosystem.
Explore EcosystemFrom molecule to medicine - follow a drug's 10-15 year journey through discovery, testing, trials, and FDA approval with NAMs at each stage.
Follow the JourneyFrom the 1938 Federal Food, Drug, and Cosmetic Act mandating animal testing to the 2022 FDA Modernization Act 2.0 ending that requirement.
See TimelineSide-by-side comparison of accuracy, cost, time, and ethical considerations between traditional animal models and modern alternatives.
Compare NowHow microfluidic organ chips mimic human physiology - channels, membranes, and living cells working together on a tiny device.
See How It WorksFrom patient data to virtual simulation - how digital twins are created, validated, and used to predict drug responses.
Explore PipelineWatch stem cells transform into mini-organs - the step-by-step process of growing brain, liver, kidney, and gut organoids in the lab.
Watch GrowthThe landmark legislation explained - how the 2022 Act and 2023 updates are transforming drug testing requirements in the United States.
Read the LawInteractive world map comparing NAMs adoption across FDA, EMA, PMDA, and other regulatory agencies worldwide.
Explore MapVisual guide to all phases of clinical trials - from Phase 0 to Phase 4, success rates, and how NAMs improve each stage.
View PhasesHow patient-derived organoids, digital twins, and AI enable personalized drug selection for individual patients.
ExploreCompare traditional animal toxicity testing with NAMs approaches - accuracy, speed, and cost differences visualized.
Compare MethodsUnderstanding biomarkers in drug development - diagnostic, prognostic, predictive, and how NAMs accelerate discovery.
Learn MoreReal-world breakthroughs - how organ chips, organoids, and AI have already saved lives and accelerated drug development.
See BreakthroughsSide-by-side analysis of traditional vs NAMs costs - from $2.6B to under $1B per drug. See where the savings come from.
See SavingsHow machine learning and AI accelerate every stage of drug development - from target ID to clinical trials in record time.
Explore AIInside look at organ-on-chip technology - liver, heart, lung, brain, kidney, and gut chips explained with visuals.
Dive InWhat healthcare looks like in 2030 and beyond - digital twins, personalized drugs, AI diagnosis, and post-animal testing world.
See the FutureThe biological differences between species that make animal testing unreliable - backed by data and case studies.
See the EvidenceHow drugs move through the body - Absorption, Distribution, Metabolism, Excretion explained with NAMs models.
Explore ADMECase studies of drugs that passed animal tests but failed in humans - Thalidomide, TGN1412, Vioxx and more.
Learn from FailuresHow induced pluripotent stem cells create patient-specific models for any tissue type - the foundation of personalized NAMs.
Explore iPSCsTumor organoids, patient-derived models, and how NAMs are transforming oncology with 95% of cancer drugs failing trials.
Explore OncologyBrain organoids, BBB models, and human-relevant approaches for Alzheimer's, Parkinson's, and neurological research.
Explore Brain NAMsHeart-on-chip, iPSC-cardiomyocytes, and QT prolongation testing - cardiac safety is #1 cause of drug withdrawals.
Explore Heart NAMsAI, machine learning, QSAR models, and computational approaches for predicting human drug responses without animals.
Explore AI/MLPrinting human tissues layer by layer - bioinks, bioprinters, and creating complex tissue structures for drug testing.
Explore BioprintingPatient-derived iPSCs create disease models when no animal model exists - hope for 300 million people worldwide.
Explore Rare DiseaseReplace, Reduce, Refine - the ethical framework guiding transition to human-relevant research methods.
Learn the 3RsAddressing the gender gap in drug development - why 80% of withdrawn drugs affected women more.
Explore Women's HealthGrowing career opportunities in organ-on-chip engineering, computational toxicology, stem cell science, and more.
Explore Careers